Associations Between Thinner Retinal Neuronal Layers and Suboptimal Brain Structural Integrity in a Middle-Aged Cohort

Purpose The retina has potential as a biomarker of brain health and Alzheimer’s disease (AD) because it is the only part of the central nervous system which can be easily imaged and has advantages over brain imaging technologies. Few studies have compared retinal and brain measurements in a middle-aged sample. The objective of our study was to investigate whether retinal neuronal measurements were associated with structural brain measurements in a middle-aged population-based cohort. Participants and Methods Participants were members of the Dunedin Multidisciplinary Health and Development Study (n=1037; a longitudinal cohort followed from birth and at ages 3, 5, 7, 9, 11, 13, 15, 18, 21, 26, 32, 38, and most recently at age 45, when 94% of the living Study members participated). Retinal nerve fibre layer (RNFL) and ganglion cell-inner plexiform layer (GC-IPL) thickness were measured by optical coherence tomography (OCT). Brain age gap estimate (brainAGE), cortical surface area, cortical thickness, subcortical grey matter volumes, white matter hyperintensities, were measured by magnetic resonance imaging (MRI). Results Participants with both MRI and OCT data were included in the analysis (RNFL n=828, female n=413 [49.9%], male n=415 [50.1%]; GC-IPL n=825, female n=413 [50.1%], male n=412 [49.9%]). Thinner retinal neuronal layers were associated with older brain age, smaller cortical surface area, thinner average cortex, smaller subcortical grey matter volumes, and increased volume of white matter hyperintensities. Conclusion These findings provide evidence that the retinal neuronal layers reflect differences in midlife structural brain integrity consistent with increased risk for later AD, supporting the proposition that the retina may be an early biomarker of brain health.

[1]  R. Poulton,et al.  The Dunedin study after half a century: reflections on the past, and course for the future , 2022, Journal of the Royal Society of New Zealand.

[2]  T. Moffitt,et al.  The limitations of large-scale volunteer databases to address inequalities and global challenges in health and aging , 2022, Nature Aging.

[3]  J. Salazar,et al.  The relationship between retinal layers and brain areas in asymptomatic first-degree relatives of sporadic forms of Alzheimer’s disease: an exploratory analysis , 2022, Alzheimer's research & therapy.

[4]  D. Tordesillas-Gutiérrez,et al.  The retinal ganglion cell layer reflects neurodegenerative changes in cognitively unimpaired individuals , 2022, Alzheimer's research & therapy.

[5]  R. Poulton,et al.  The prevalence of glaucoma among 45-year-old New Zealanders. , 2022, The New Zealand medical journal.

[6]  T. Ninomiya,et al.  Association of Inner Retinal Thickness with Prevalent Dementia and Brain Atrophy in a General Older Population , 2022, Ophthalmology science.

[7]  R. Poulton,et al.  Associations Between Retinal Nerve Fiber Layer and Ganglion Cell Layer in Middle Age and Cognition From Childhood to Adulthood. , 2022, JAMA ophthalmology.

[8]  OUP accepted manuscript , 2022, Age And Ageing.

[9]  T. Wong,et al.  Retinal imaging in Alzheimer’s disease , 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

[10]  L. Tan,et al.  Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis , 2021, Ageing Research Reviews.

[11]  C. Cheung,et al.  Artificial intelligence and machine learning for Alzheimer’s disease: let’s not forget about the retina , 2021, British Journal of Ophthalmology.

[12]  T. Ziemssen,et al.  Relation of retinal and hippocampal thickness in patients with amnestic mild cognitive impairment and healthy controls , 2021, Brain and behavior.

[13]  A. Sadun,et al.  OCT parameters of the optic nerve head and the retina as surrogate markers of brain volume in a normal population, a pilot study , 2020, Journal of the Neurological Sciences.

[14]  J. Crowston,et al.  Retinal energy metabolism in health and glaucoma , 2020, Progress in Retinal and Eye Research.

[15]  Charles A Reisman,et al.  Relationships between retinal layer thickness and brain volumes in the UK Biobank cohort , 2020, European journal of neurology.

[16]  J. Morris,et al.  Possible Consequences of the Approval of a Disease-Modifying Therapy for Alzheimer Disease. , 2020, JAMA neurology.

[17]  V. Pelak,et al.  Optical Coherence Tomography in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis , 2020, Frontiers in Neurology.

[18]  M. Castelo‐Branco,et al.  The Retinal Inner Plexiform Synaptic Layer Mirrors Grey Matter Thickness of Primary Visual Cortex with Increased Amyloid β Load in Early Alzheimer's Disease , 2020, Neural plasticity.

[19]  Justis P. Ehlers,et al.  Correlation between brain volume and retinal photoreceptor outer segment volume in normal aging and neurodegenerative diseases , 2020, PloS one.

[20]  L. Younes,et al.  Entorhinal and Transentorhinal Atrophy in Preclinical Alzheimer's Disease , 2020, Frontiers in Neuroscience.

[21]  H. Chui,et al.  Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline , 2020, PloS one.

[22]  Raymond P. Najjar,et al.  Artificial Intelligence to Detect Papilledema from Ocular Fundus Photographs. , 2020, The New England journal of medicine.

[23]  S. Salloway,et al.  Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[24]  Chunbo Li,et al.  Retinal nerve fiber layer thickness is associated with hippocampus and lingual gyrus volumes in nondemented older adults , 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[25]  Christine T. O. Nguyen,et al.  Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer’s disease , 2019, Nature Communications.

[26]  Annchen R. Knodt,et al.  Brain-age in midlife is associated with accelerated biological aging and cognitive decline in a longitudinal birth cohort , 2019, bioRxiv.

[27]  P. Scheltens,et al.  Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer’s disease , 2019, Alzheimer's Research & Therapy.

[28]  Chunbo Li,et al.  Retinal Nerve Fiber Layer Thinning Is Associated With Brain Atrophy: A Longitudinal Study in Nondemented Older Adults , 2019, Front. Aging Neurosci..

[29]  T. Wong,et al.  Spectral-Domain OCT Measurements in Alzheimer's Disease: A Systematic Review and Meta-analysis. , 2019, Ophthalmology.

[30]  Ahmad R. Hariri,et al.  White matter hyperintensities are common in midlife and already associated with cognitive decline , 2019, bioRxiv.

[31]  J. Dartigues,et al.  Association of Retinal Nerve Fiber Layer Thickness With Brain Alterations in the Visual and Limbic Networks in Elderly Adults Without Dementia , 2018, JAMA network open.

[32]  Geraint Rees,et al.  Association of Retinal Nerve Fiber Layer Thinning With Current and Future Cognitive Decline: A Study Using Optical Coherence Tomography , 2018, JAMA neurology.

[33]  C. Klaver,et al.  Thinner retinal layers are associated with changes in the visual pathway: A population‐based study , 2018, Human brain mapping.

[34]  P. Selnes,et al.  Similar pattern of atrophy in early- and late-onset Alzheimer's disease , 2018, Alzheimer's & dementia.

[35]  Peter J. Snyder,et al.  Change in retinal structural anatomy during the preclinical stage of Alzheimer's disease , 2018, Alzheimer's & dementia.

[36]  J. Kramer,et al.  Retinal thinning is uniquely associated with medial temporal lobe atrophy in neurologically normal older adults , 2017, Neurobiology of Aging.

[37]  T. Wong,et al.  Imaging retina to study dementia and stroke , 2017, Progress in Retinal and Eye Research.

[38]  Daniel S. Margulies,et al.  Predicting brain-age from multimodal imaging data captures cognitive impairment , 2016, NeuroImage.

[39]  P. Bosco,et al.  Brain atrophy in Alzheimer’s Disease and aging , 2016, Ageing Research Reviews.

[40]  Jesper Andersson,et al.  A multi-modal parcellation of human cerebral cortex , 2016, Nature.

[41]  Richie Poulton,et al.  The Dunedin Multidisciplinary Health and Development Study: overview of the first 40 years, with an eye to the future , 2015, Social Psychiatry and Psychiatric Epidemiology.

[42]  T. Wong,et al.  Retinal neurodegeneration on optical coherence tomography and cerebral atrophy , 2015, Neuroscience Letters.

[43]  Keith A. Johnson,et al.  The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials , 2014, Neuron.

[44]  T. Röck,et al.  Influence of axial length on thickness measurements using spectral-domain optical coherence tomography. , 2014, Investigative ophthalmology & visual science.

[45]  M. Schwartz,et al.  The retina as a window to the brain—from eye research to CNS disorders , 2013, Nature Reviews Neurology.

[46]  T. Wong,et al.  Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[47]  Keith L. Black,et al.  Alzheimer’s Disease in the Retina: Imaging Retinal Aβ Plaques for Early Diagnosis and Therapy Assessment , 2012, Neurodegenerative Diseases.

[48]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[49]  C. Miller,et al.  Optic-nerve degeneration in Alzheimer's disease. , 1986, The New England journal of medicine.